Stanford, CA, United States of America

Marvin H Gee

This inventor holds 1 USPTO granted patent. Top assignee: California Institute of Technology. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marvin H Gee. Retrieved from https://idiyas.com/inventor/marvin-h-gee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marvin H. Gee: Innovator in Genetically Engineered T Cell Receptors

Introduction

Marvin H. Gee is a prominent inventor based in Stanford, California. He has made significant contributions to the field of immunology, particularly in the development of genetically engineered T cell receptors. His work has the potential to advance therapeutic strategies for various diseases.

Latest Patents

Marvin H. Gee holds a patent for "Domain-swap T cell receptors." This patent discloses genetically engineered T cell receptors, along with methods, vectors, and genetically engineered T cells related to these receptors. His innovative approach aims to enhance the efficacy of T cell therapies.

Career Highlights

Marvin is affiliated with the California Institute of Technology, where he continues to push the boundaries of research in immunotherapy. His work has garnered attention for its potential applications in treating cancer and other immune-related conditions.

Collaborations

Throughout his career, Marvin has collaborated with notable scientists, including Michael Thomas Bethune and David Baltimore. These partnerships have enriched his research and contributed to advancements in the field.

Conclusion

Marvin H. Gee's contributions to the development of genetically engineered T cell receptors exemplify the innovative spirit of modern science. His work not only highlights the importance of collaboration in research but also paves the way for future breakthroughs in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…